TY  - BOOK
CN  - Y 4.G 74/7:R 49/3
CN  - KF27
CY  - Washington :
DA  - 2005.
ID  - 299281
KW  - Rofecoxib
KW  - Nonsteroidal anti-inflammatory agents
KW  - Nonsteroidal anti-inflammatory agents
KW  - Drugs
KW  - Drugs
LK  - http://purl.access.gpo.gov/GPO/LPS63169
LK  - http://purl.access.gpo.gov/GPO/LPS63170
N1  - Distributed to some depository libraries in microfiche.
N1  - Shipping list no.: 2005-0227-P.
N1  - Errata shipping list no. unavailable.
N1  - Published record lacks prepared statement of Rep. Charles W. Dent.
N1  - "Serial no. 109-27."
PB  - U.S. G.P.O. :
PB  - For sale by the Supt. of Docs., U.S. G.P.O.,
PP  - Washington :
PY  - 2005.
SN  - 0160749336
T1  - Risk and responsibility :the roles of FDA and pharmaceutical companies in ensuring the safety of approved drugs, like Vioxx : hearing before the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, first session, May 5, 2005.
TI  - Risk and responsibility :the roles of FDA and pharmaceutical companies in ensuring the safety of approved drugs, like Vioxx : hearing before the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, first session, May 5, 2005.
UR  - http://purl.access.gpo.gov/GPO/LPS63169
UR  - http://purl.access.gpo.gov/GPO/LPS63170
ER  -